EPITOPE INC/OR/
8-K, 2000-09-29
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: PAREXEL INTERNATIONAL CORP, DEF 14A, 2000-09-29
Next: PARLUX FRAGRANCES INC, 10-Q/A, 2000-09-29



                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                              --------------------

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                Date of Report (Date of earliest event reported):

                               September 29, 2000

                                -----------------


                                  EPITOPE, INC.
             (Exact name of Registrant as specified in its charter)

           OREGON                    1-10492                     93-0779127
(State or other jurisdiction       (Commission                 (IRS Employer
     of incorporation)               File No.)               Identification No.)

                             8505 SW Creekside Place
                          Beaverton, Oregon 97008-7108
               (Address of principal executive offices) (Zip code)

                                 (503) 641-6115
              (Registrant's telephone number, including area code)


<PAGE>

ITEM 8.  CHANGE IN FISCAL YEAR.

On September 29, 2000, the board of directors of Company adopted a resolution to
change the  Company's  fiscal  year from a year  ending  September  30 to a year
ending  December  31. The Company  intends to file a report on Form 10-Q for the
quarter ending  September 30, 2000, and a report on Form 10-K for the year ended
December 31, 2000.




<PAGE>


                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                            EPITOPE, INC.


Dated:  September 29, 2000                  By:/s/ Charles E. Bergeron
                                            Charles E. Bergeron
                                            Chief Financial Officer




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission